AllianceBernstein’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-109,460
| Closed | -$982K | – | 3097 |
|
|
2016
Q3 | $982K | Hold |
109,460
| – | – | ﹤0.01% | 2233 |
|
|
2016
Q2 | $588K | Hold |
109,460
| – | – | ﹤0.01% | 2457 |
|
|
2016
Q1 | $504K | Sell |
109,460
-11,700
| -10% | -$47K | ﹤0.01% | 2415 |
|
|
2015
Q4 | $630K | Hold |
121,160
| – | – | ﹤0.01% | 2357 |
|
|
2015
Q3 | $733K | Sell |
121,160
-140
| -0.1% | -$1.72K | ﹤0.01% | 2321 |
|
|
2015
Q2 | $1.92M | Buy |
121,300
+11,700
| +11% | +$142K | ﹤0.01% | 1838 |
|
|
2015
Q1 | $1.19M | Hold |
109,600
| – | – | ﹤0.01% | 2097 |
|
|
2014
Q4 | $1.15M | Hold |
109,600
| – | – | ﹤0.01% | 2122 |
|
|
2014
Q3 | $1.05M | Hold |
109,600
| – | – | ﹤0.01% | 2167 |
|
|
2014
Q2 | $1.27M | Sell |
109,600
-237
| -0.2% | -$2.16K | ﹤0.01% | 2105 |
|
|
2014
Q1 | $1.1M | Buy |
109,837
+237
| +0.2% | +$3.42K | ﹤0.01% | 2115 |
|
|
2013
Q4 | $1.43M | Buy |
109,600
+1,500
| +1% | +$20.7K | ﹤0.01% | 1949 |
|
|
2013
Q3 | $1.61M | Buy |
108,100
+41,417
| +62% | +$496K | ﹤0.01% | 1832 |
|
|
2013
Q2 | $623K | Buy |
+66,683
| New | +$452K | ﹤0.01% | 2354 |
|
AllianceBernstein's RPTP Position: Q4 2016 in Review
AllianceBernstein sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 109,460 shares — an estimated $982K sold.
AllianceBernstein first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $1.92M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- AllianceBernstein reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- AllianceBernstein sold 109,460 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $982K.
- AllianceBernstein first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
- AllianceBernstein's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.92M in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.